Zone Labs Inc. Participates In ERSP Forum

New York, NY – Nov. 29, 2007 – The Electronic Retailing Self-Regulation Program (ERSP) has announced that Zone Labs Inc. has discontinued and modified several performance claims and modified one comparative claim in advertising for the Zone OmegaRx Capsules. The marketer’s advertising came to ERSP’s attention pursuant to an anonymous challenge.

ERSP, the electronic direct-response industry’s self-regulatory forum, is administered by the Council of Better Business Bureaus (CBBB) with policy oversight by the National Advertising Review Council (NARC).

Claims at issue in the ERSP inquiry included:

  • “The quickest and easiest way to control inflammation within the fat cells”
  • “Burns Excess Fat”
  • “Enables you to reduce excess body fat”
  • “EPA helps quench inflammation within the fat cells while also naturally inhibiting the brains hunger signals”
  • “EPA promotes the use of fat as energy from your fat cells”
  • “Helps to reduce inflammation within the fat cells to minimize the spread of inflammation to other organs to support the body’s defense against chronic illness”
  • “Patented science from Dr. Barry Sears, the world leader in Omega-3 fatty acids research”
  • “OmegaRx has the highest concentration of EPA and DHA on the market”

During the inquiry, the marketer significantly revised the online advertising that was the subject of the anonymous challenge and most of the performance claims were voluntarily discontinued.

In addition, ERSP determined that the remaining claims at issue were modified in a manner that was consistent with the marketer’s substantiating data.

Finally, ERSP determined that the marketer’s trade name – in light of the other modifications – was not misleading.

The company, in its marketer’s statement, said “Although Zone Labs believed the performance claims at issue were well supported by the substantiating data it submitted, for reasons unrelated to the inquiry it agreed to discontinue certain claims in the context they were made. Zone Labs fully supports and appreciates NARC’s self-regulatory process.”